This study is for people already taking niraparib in a previous trial. Niraparib is a medicine used to treat some types of cancer. The study helps to continue receiving this treatment and checks if it is safe to use for a long time. To join, participants need to understand and agree to the study rules, still be benefiting from niraparib, and able to follow the schedule. They must use contraception during and after the study if they can have children.
- Participants must already be taking niraparib in a previous study.
- They cannot be pregnant or breastfeeding during the study.
- Participation requires understanding and agreeing to follow all study rules.